Issue Date | Title | Involved Person(s) |
14-Feb-2024 | Suicide rates and prescription of antidepressants | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
2024 | Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder : a systematic review with meta-analysis and trial sequential analysis | Kamp, Caroline Barkholt; Petersen, Johanne Juul; Faltermeier, Pascal; Juul, Sophie; Siddiqui, Faiza, et al |
15-Nov-2023 | Antidepressants use in Italy : an ecological study of national and regional trends and associated factors | Amendola, Simone; Hengartner, Michael Pascal |
5-Sep-2023 | Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population | Amrein, Melanie A.; Hengartner, Michael P.; Näpflin, Markus; Farcher, Renato; Huber, Carola A. |
20-Jun-2023 | The government has a moral duty to help those harmed by prescribed dependence forming drugs | Davies, James; Horowitz, Mark; Montagu, Luke; Hollins, Sheila; Read, John, et al |
30-Mar-2023 | The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder : a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis | Jørgensen, Caroline Kamp; Juul, Sophie; Siddiqui, Faiza; Horowitz, Mark Abie; Moncrieff, Joanna, et al |
14-Dec-2022 | Estimating risk of antidepressant withdrawal from a review of published data | Horowitz, Mark Abie; Framer, Adele; Hengartner, Michael P.; Sørensen, Anders; Taylor, David |
17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
2021 | Prophylactic effects or withdrawal reactions? : an analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA | Hengartner, Michael Pascal; Plöderl, Martin |
2021 | Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses | Juul, Sophie; Siddiqui, Faiza; Barbateskovic, Marija; Jørgensen, Caroline Kamp; Hengartner, Michael Pascal, et al |
2021 | Suicidality and other severe psychiatric events with duloxetine : re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia | Hengartner, Michael Pascal; Plöderl, Martin |
2021 | Swiss GPs’ preferences for antidepressant treatment in mild depression : vignette-based quantitative analysis | Hengartner, Michael P.; Neuner-Jehle, Stefan; Senn, Oliver |
2021 | Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder : a protocol for a systematic review with meta-analysis and Trial Sequential Analysis | Jørgensen, Caroline Kamp; Juul, Sophie; Siddiqui, Faiza; Barbateskovic, Marija; Munkholm, Klaus, et al |
25-Nov-2020 | Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates? | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
2020 | Editorial : antidepressant prescriptions in children and adolescents | Hengartner, Michael Pascal |